相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
Ben T. Copeland et al.
MOLECULAR CANCER RESEARCH (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling
Jiaping Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder
Qiong Zou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: A novel antiangiogenic therapy
Taro Kamisasanuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The complexity of tetraspanins
Eric Rubinstein
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Tetraspanin CD9 in cell migration
Dale Powner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Tetraspanin CD151 Regulates Transforming Growth Factor β Signaling: Implication in Tumor Metastasis
Rafal Sadej et al.
CANCER RESEARCH (2010)
Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy
Serdar Soyuer et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
Taisei Nakamoto et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation
Mayumi Suzuki et al.
JOURNAL OF IMMUNOLOGY (2009)
CD9 negatively regulates integrin alpha(IIb)beta(3) activation and could thus prevent excessive platelet recruitment at sites of vascular injury
P. H. Mangin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Tetraspanins: push and pull in suppressing and promoting metastasis
Margot Zoeller
NATURE REVIEWS CANCER (2009)
Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer
Teresa Chiaverotti et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis
Youya Nakazawa et al.
BLOOD (2008)
Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival
Elke De Bruyne et al.
CLINICAL CANCER RESEARCH (2008)
Origin of androgen-insensitive poorly differentiated tumors in the Transgenic adenocarcinoma of mouse prostate model
Wendy J. Huss et al.
NEOPLASIA (2007)
Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications
Jia-Chi Wang et al.
CLINICAL CANCER RESEARCH (2007)
Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model
Takayuki Takeda et al.
CANCER RESEARCH (2007)
Reduced fertility of female mice lacking CD81
E Rubinstein et al.
DEVELOPMENTAL BIOLOGY (2006)
Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells
V Zvierev et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Tetraspanin functions and associated microdomains
ME Hemler
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Androgens induce CD-9 in human prostate tissue
Y Chuan et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2005)
CD9 expression in gastric cancer and its significance
H Hori et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck
P Mhawech et al.
BRITISH JOURNAL OF CANCER (2004)
MRP-1/CD9 gene transduction downregulates Wnt signal pathways
CL Huang et al.
ONCOGENE (2004)
CD9 expression is not a prognostic factor in human osteosarcoma
B Kubista et al.
CANCER LETTERS (2004)
Motility-related protein 1 (MRP-1/09) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression
P Mhawech et al.
CANCER (2003)
Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma
BM Erovic et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2003)
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
PJ Kaplan-Lefko et al.
PROSTATE (2003)
Integrin α3 expression as a prognostic factor in colon cancer:: Association with MRP-1/CD9 and KAI1/CD82
H Hashida et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells
N Longo et al.
BLOOD (2001)
Tetraspanins
C Boucheix et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis
J Kusukawa et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2001)
Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery
M Miyake et al.
ONCOGENE (2000)
Severely reduced female fertility in CD9-deficient mice
F Le Naour et al.
SCIENCE (2000)
Requirement of CD9 on the egg plasma membrane for fertilization
K Miyado et al.
SCIENCE (2000)
分享论文
